Psychotropic Med Use Tied to ‘Striking’ Post-COVID Dementia Risk
Older adults taking psychotropic medication before contracting COVID-19 are at increased risk dementia in the year following the illness, new research suggests.
Results from a large study of more than 1700 patients who had been hospitalized with COVID showed a greater than twofold increased risk for post-COVID dementia in those taking antipsychotics and mood stabilizers/anticonvulsants — medications often used to treat schizophrenia, psychosis, bipolar disorder, and seizures.